[Federal Register Volume 89, Number 41 (Thursday, February 29, 2024)]
[Notices]
[Page 14846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04199]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP-24-046, Nationwide Cohort To Estimate 
Burden of Respiratory Viruses and Immunologic Response (Blood Donor 
Cohort); Amended Notice of Closed Meeting

    Notice is hereby given of a change in the closed meeting of the 
Disease, Disability, and Injury Prevention and Control Special Emphasis 
Panel (SEP)--RFA-IP-24-046, Nationwide Cohort to Estimate Burden of 
Respiratory Viruses and Immunologic Response (Blood Donor Cohort); 
April 11-12, 2024, 10 a.m.-5 p.m., EDT, videoconference, in the 
original Federal Register notice. The meeting notice was published in 
the Federal Register on January 16, 2024, Volume 89, Number 10, pages 
2618-2619.
    The notice is being amended to change the meeting dates to a one-
day meeting and should read as follows:
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-IP-24-046, Nationwide Cohort 
to Estimate Burden of Respiratory Viruses and Immunologic Response 
(Blood Donor Cohort).
    Date: April 11, 2024.
    Time: 10 a.m.-5 p.m., EDT.
    The meeting is closed to the public.

    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop H24-6, Atlanta, Georgia 30329-4027. 
Telephone: (404) 718-8833; Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04199 Filed 2-28-24; 8:45 am]
BILLING CODE 4163-18-P